STOCK TITAN

Philips announces collaboration with Epic to enhance ambulatory cardiac monitoring

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Philips (NYSE: PHG) has announced a strategic collaboration with Epic to integrate its cardiac ambulatory monitoring and diagnostics services with Epic's Aura specialty diagnostics platform. This integration will create the largest cardiac care portfolio available through Epic's Aura platform to date.

The collaboration aims to enhance interoperability between Philips' monitoring technologies and Epic's systems, allowing healthcare providers to order and review ECG results directly within Epic. Key benefits include automated patient activation, staff notifications, and charting, significantly reducing manual data entry and streamlining workflow efficiencies for cardiac care teams.

Philips (NYSE: PHG) ha annunciato una collaborazione strategica con Epic per integrare i suoi servizi di monitoraggio cardiaco ambulatoriale e diagnostica con la piattaforma di diagnostica specialistica Aura di Epic. Questa integrazione darà vita al più ampio portafoglio di cure cardiache disponibile finora sulla piattaforma Aura di Epic.

La collaborazione mira a migliorare l'interoperabilità tra le tecnologie di monitoraggio di Philips e i sistemi di Epic, permettendo ai professionisti sanitari di ordinare e consultare i risultati ECG direttamente all'interno di Epic. I principali vantaggi includono l'attivazione automatica del paziente, le notifiche al personale e la documentazione, riducendo notevolmente l'inserimento manuale dei dati e ottimizzando l'efficienza del flusso di lavoro per i team di assistenza cardiaca.

Philips (NYSE: PHG) ha anunciado una colaboración estratégica con Epic para integrar sus servicios de monitorización cardíaca ambulatoria y diagnóstico con la plataforma de diagnóstico especializado Aura de Epic. Esta integración creará el portafolio de cuidados cardíacos más grande disponible hasta la fecha a través de la plataforma Aura de Epic.

La colaboración tiene como objetivo mejorar la interoperabilidad entre las tecnologías de monitorización de Philips y los sistemas de Epic, permitiendo a los proveedores de salud ordenar y revisar resultados de ECG directamente dentro de Epic. Los beneficios clave incluyen la activación automática del paciente, notificaciones al personal y registro de datos, lo que reduce significativamente la entrada manual de datos y optimiza la eficiencia del flujo de trabajo para los equipos de atención cardíaca.

필립스 (NYSE: PHG)는 Epic과 전략적 협력을 발표하여 심장 외래 모니터링 및 진단 서비스를 Epic의 Aura 전문 진단 플랫폼과 통합합니다. 이 통합을 통해 지금까지 Epic의 Aura 플랫폼에서 제공되는 가장 큰 심장 치료 포트폴리오가 구축됩니다.

이번 협력은 필립스의 모니터링 기술과 Epic 시스템 간 상호운용성을 향상시켜 의료 제공자가 Epic 내에서 ECG 결과를 직접 주문하고 검토할 수 있도록 하는 것을 목표로 합니다. 주요 이점으로는 자동 환자 활성화, 직원 알림, 차트 작성 등이 포함되어 수작업 데이터 입력을 크게 줄이고 심장 치료 팀의 업무 효율성을 향상시킵니다.

Philips (NYSE : PHG) a annoncé une collaboration stratégique avec Epic afin d’intégrer ses services de surveillance ambulatoire cardiaque et de diagnostic à la plateforme de diagnostics spécialisés Aura d’Epic. Cette intégration créera le plus grand portefeuille de soins cardiaques disponible à ce jour via la plateforme Aura d’Epic.

Cette collaboration vise à améliorer l’interopérabilité entre les technologies de surveillance de Philips et les systèmes d’Epic, permettant aux professionnels de santé de commander et consulter les résultats ECG directement au sein d’Epic. Les principaux avantages incluent l’activation automatique des patients, les notifications au personnel et la saisie des données, réduisant ainsi considérablement la saisie manuelle et optimisant l’efficacité des flux de travail pour les équipes de soins cardiaques.

Philips (NYSE: PHG) hat eine strategische Zusammenarbeit mit Epic angekündigt, um seine ambulanten Herzüberwachungs- und Diagnosedienste in die Spezialdiagnoseplattform Aura von Epic zu integrieren. Diese Integration wird das größte Portfolio für Herzversorgung schaffen, das bisher über die Aura-Plattform von Epic verfügbar ist.

Die Zusammenarbeit zielt darauf ab, die Interoperabilität zwischen Philips' Überwachungstechnologien und den Systemen von Epic zu verbessern, sodass Gesundheitsdienstleister EKG-Ergebnisse direkt innerhalb von Epic anfordern und einsehen können. Zu den wichtigsten Vorteilen zählen die automatisierte Patientenaktivierung, Benachrichtigungen für das Personal und die Dokumentation, was die manuelle Dateneingabe erheblich reduziert und die Arbeitsabläufe für Herzversorgungsteams optimiert.

Positive
  • Integration creates largest cardiac care portfolio available through Epic's Aura platform
  • Reduces manual data entry and streamlines workflow for healthcare providers
  • Automates patient activation, staff notifications, and charting processes
  • Enables direct ECG results review within Epic's system
Negative
  • None.

Insights

Philips' Epic integration expands market reach for cardiac monitoring while streamlining clinical workflows and potentially driving revenue growth.

Philips' new collaboration with Epic represents a significant strategic expansion of its cardiac care capabilities. By integrating with Epic's Aura platform, Philips will offer what they claim is the largest cardiac care portfolio through a major EHR system, giving them enhanced market positioning against competitors.

The integration delivers two crucial competitive advantages. First, it reduces implementation friction by simplifying the connection process between Philips' ambulatory monitoring technologies and healthcare IT systems. Second, it streamlines clinical workflows by enabling providers to order and review ECG results directly within Epic, eliminating manual data entry and potentially accelerating diagnosis timelines.

This collaboration addresses a critical pain point in healthcare delivery - the administrative burden on cardiac care teams. By automating patient activation, staff notifications, and charting, Philips is positioning its technology to enhance operational efficiency while improving both clinician experience and patient care.

For Philips investors, this represents a strategic enhancement of their cardiac monitoring portfolio that could drive increased adoption among Epic's extensive customer base of healthcare systems. While revenue impact isn't immediately quantifiable, the expanded accessibility and workflow improvements could contribute to sustainable growth in Philips' ambulatory monitoring division by reducing barriers to adoption and increasing market penetration.

July 24, 2025

Philips will now offer the largest cardiac care portfolio through Epic’s Aura platform

CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips’ suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic health record (EHR) company. This collaboration will offer the broadest cardiac care portfolio of any single service provider integrating with Aura to date. Philips will deliver a new level of interoperability between its ambulatory monitoring technologies and Epic—helping providers enhance the diagnostic process and improve patient outcomes.

With Philips’ technology available through Aura, health system IT teams could significantly reduce the time it takes to connect with Philips [1] and give interested provider organizations the ability to order and review patients’ ECG results directly in Epic. This cuts out the need for manual order and data entry, which enhances workflows for providers and streamlines data-driven care decisions.

“With this collaboration, we are advancing cardiac care in a way that simultaneously improves the clinician and patient experience,” said Stefano Folli, Business Leader, Ambulatory Monitoring & Diagnostics, Philips. “Together, Philips and Epic can help enable workflow efficiencies that lighten cardiac care teams’ load, so they can spend more time focusing on what matters most – providing direct patient care.”

The Philips-Epic collaboration can also streamline cumbersome administrative tasks by automating patient activation, staff notifications, and charting – giving valuable time back to cardiology teams to spend with patients.

“When a physician prescribes a cardiac monitor, it allows patients to be evaluated for heart conditions as they go about their daily lives, even before they see a cardiologist,” said Leah Johnson, vice president of cardiology and imaging diagnostics, Epic. “Through this collaboration, we’re streamlining the clinical experience for both patients and physicians, reducing administrative overhead and ensuring that detailed diagnostic reports are readily available in the patient’s comprehensive health record.”

The Philips ambulatory monitoring portfolio features flexible remote monitoring and enterprise ECG management solutions designed to advance a new standard of cardiac care. By arming healthcare organizations with data and actionable insights that can transform workflows to diagnose and manage patient populations proactively, Philips’ products and services help enable care delivery in the right setting, at the right time.

[1] See, for example, American Society of Clinical Oncology. (2024). [Abstract 416274]. ASCO regarding Aura time savings on connections to external pathology laboratories. https://www.asco.org/abstracts-presentations/ABSTRACT416274

For further information, please contact:

Allison Johnson
Director, Monitoring Communications
Tel: +1 617-631-7305
E-mail: allison.johnson@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachment


FAQ

What is the new collaboration between Philips (NYSE: PHG) and Epic?

Philips is integrating its cardiac ambulatory monitoring and diagnostics services with Epic's Aura platform, creating the largest cardiac care portfolio available through Epic's specialty diagnostics suite.

How will the Philips-Epic integration benefit healthcare providers?

The integration will reduce manual data entry, enable direct ECG result review in Epic, automate patient activation and staff notifications, and streamline workflow efficiencies for cardiac care teams.

What specific features does the Philips cardiac monitoring integration with Epic offer?

The integration offers automated patient activation, staff notifications, charting capabilities, and allows providers to order and review ECG results directly within Epic's system.

How does the Philips-Epic collaboration improve patient care?

The collaboration enables more efficient cardiac monitoring by streamlining administrative tasks, giving healthcare providers more time for direct patient care and enabling data-driven care decisions.

What is included in Philips' ambulatory monitoring portfolio?

Philips' portfolio includes flexible remote monitoring and enterprise ECG management solutions designed to advance cardiac care standards and enable proactive patient population management.
Koninklijke Phil

NYSE:PHG

PHG Rankings

PHG Latest News

PHG Stock Data

23.91B
925.01M
6.49%
0.26%
Medical Devices
Healthcare
Link
Netherlands
Amsterdam